Jardiance

Jardiance Sử dụng ở phụ nữ có thai & cho con bú

empagliflozin

Nhà sản xuất:

Boehringer Ingelheim
Thông tin kê toa chi tiết tiếng Anh
Use In Pregnancy & Lactation
Pregnancy: There are limited data from the use of JARDIANCE in pregnant women. Nonclinical studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure it is recommended to avoid the use of JARDIANCE during pregnancy unless clearly needed.
Lactation: No data in humans are available on excretion of empagliflozin into milk. Available nonclinical data in animals have shown excretion of empagliflozin in milk. A risk to human newborns/infants cannot be excluded. It is recommended to discontinue breast feeding during treatment with JARDIANCE.
Fertility: No studies on the effect on human fertility have been conducted for JARDIANCE. Nonclinical studies in animals do not indicate direct or indirect harmful effects with respect to fertility.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in